Skip to main content
. 2022 Jul 20;12:12446. doi: 10.1038/s41598-022-15148-z

Table 1.

Summary of subjects’ data.

23–69 years old + 90 years old
Total number of subjects 1114 97
Gender Females Males Females Males
n (%) 732 (65.7%) 382 (34.3%) 66 (68.0%) 31 (32.0%)
Presence of anti-N antibodies Yes No Yes No
n (%) 91 (8.2%) 1023 (91.8%) 9 (9.3%) 88 (90.7%)
Months after administration of 2nd dose (mean ± SD) 6.2 ± 0.8 5.8 ± 1.1